STATE STREET CORP - 4D MOLECULAR THERAPEUTICS IN ownership

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 112 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$21,858,938
-41.0%
1,717,120
-16.3%
0.00%
-50.0%
Q2 2023$37,051,270
+5.5%
2,050,430
+0.4%
0.00%0.0%
Q1 2023$35,105,229
-36.0%
2,042,189
-17.3%
0.00%0.0%
Q4 2022$54,865,718
+907.8%
2,470,316
+264.8%
0.00%
Q3 2022$5,444,000
+23.3%
677,176
+7.1%
0.00%
Q2 2022$4,415,000
-80.4%
632,525
-57.5%
0.00%
-100.0%
Q1 2022$22,519,000
-18.5%
1,489,371
+18.2%
0.00%0.0%
Q4 2021$27,637,000
+220.6%
1,259,660
+294.1%
0.00%
Q3 2021$8,621,000
+116.3%
319,662
+93.2%
0.00%
Q2 2021$3,985,000
-14.0%
165,492
+54.9%
0.00%
Q1 2021$4,634,000106,8330.00%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 3,000,000$38,190,0004.02%
Casdin Capital, LLC 1,033,811$13,160,4141.46%
BVF INC/IL 4,007,413$51,014,3671.38%
Deep Track Capital, LP 2,778,107$35,365,3021.36%
Opaleye Management Inc. 308,500$3,927,2051.28%
Eagle Health Investments LP 437,911$5,574,6071.23%
Novo Holdings A/S 1,200,000$15,276,0001.13%
RA Capital Management 4,163,211$52,997,6761.04%
VIKING GLOBAL INVESTORS LP 4,787,914$60,950,1450.25%
HighVista Strategies LLC 33,419$425,4240.20%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders